For the first time, a protein critical in cancer cell metabolism has been imaged with the…
During its 2021 Virtual Annual Meeting last week, the Society of Nuclear Medicine and…
A novel cancer treatment approach uses light from decaying radiopharmaceuticals, known as…
Telix Pharmaceuticals, in partnership with Applied Radiology, launched TelixU, a new…
Research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021…
Subtle Medical announced CE Mark for the second generation of their SubtlePET image…
Telix Pharmaceuticals Ltd. has launched a new website as part of the company’s gallium…
The alpha-radiation cancer therapy Alpha DaRT has received a Breakthrough Device Designation…
The first radiopharmaceutical agent specifically designed for targeted lymphatic mapping and…
A new study from the Institut national de la recherche scientifique (INRS) shows that…
